Apogee Therapeutics Inc (NASDAQ:APGE) shares, rose in value on Friday, June 20, with the stock price up by 1.89% to the previous day’s close as strong demand from buyers drove the stock to $41.96.
Actively observing the price movement in the last trading, the stock closed the session at $41.18. Referring to stock’s 52-week performance, its high was $63.50, and the low was $26.20. On the whole, APGE has fluctuated by 4.02% over the past month.
With the market capitalization of Apogee Therapeutics Inc currently standing at about $2.50 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-12.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that APGE’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of Hold while long-term indicators on average have been pointing out that it is a Hold.
The stock’s technical analysis shows that the price of APGE currently trading nearly 5.65% and 10.52% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 56.93, while the 7-day volatility ratio is showing 2.57% which for the 30-day chart, stands at 3.66%. Furthermore, Apogee Therapeutics Inc (APGE)’s beta value is 1.39, and its average true range (ATR) is 2.42.
A comparison of Apogee Therapeutics Inc (APGE) with its peers suggests the former has fared considerably weaker in the market. APGE showed an intraday change of 1.89% in last session, and over the past year, it grew by 7.62%%.
Data on historical trading for Apogee Therapeutics Inc (NASDAQ:APGE) indicates that the trading volumes over the past 3 months, they’ve averaged 722.83K. According to company’s latest data on outstanding shares, there are 46.04 million shares outstanding.
Nearly 37.32% of Apogee Therapeutics Inc’s shares belong to company insiders and institutional investors own 88.24% of the company’s shares. The stock has fallen by -7.37% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the APGE stock heading into the next quarter.
